Sign Up to like & get
recommendations!
0
Published in 2018 at "Molecular genetics and metabolism"
DOI: 10.1016/j.ymgme.2018.02.005
Abstract: Carnitine palmitoyltransferase type 2 (CPT2) deficiency, a mitochondrial fatty acid oxidation disorder (MFAOD), is a cause of myopathy in its late clinical presentation. As for other MFAODs, its diagnosis may be evocated when blood acylcarnitine…
read more here.
Keywords:
diagnosis;
cpt2;
cohort patients;
cpt2 deficiency ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "OncoTargets and therapy"
DOI: 10.2147/ott.s163266
Abstract: Background Cancer cells often have characteristic changes in metabolism. Besides Warburg effect, abnormal lipid metabolism is also considered as one of the most typical metabolic symbols of cancer. Thus, understanding the mechanisms of cell metabolic…
read more here.
Keywords:
hepatocellular carcinoma;
chemoresistance;
chemoresistance cisplatin;
cpt2 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.1030800
Abstract: Acute kidney injury (AKI) is a common clinical syndrome with complex pathogenesis, characterized by a rapid decline in kidney function in the short term. Worse still, the incomplete recovery from AKI increases the risk of…
read more here.
Keywords:
cpt2;
mediated lipophagy;
aki ckd;
ckd transition ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2023.1186064
Abstract: Background: Tumors frequently evade immune surveillance through multiple pathways to escape T cell recognition and destruction. Previous studies indicated that lipid metabolism alteration could affect the anti-tumor immunity of cancer cells. Nonetheless, the studies that…
read more here.
Keywords:
cpt2;
lipid metabolism;
gene;
cancer ... See more keywords